Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03044561
Other study ID # amr el-sayed 2017
Secondary ID
Status Recruiting
Phase Phase 4
First received February 2, 2017
Last updated February 3, 2017
Start date January 31, 2017
Est. completion date August 10, 2017

Study information

Verified date February 2017
Source Ain Shams University
Contact ahmed khairy, professor
Phone 01090808047
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the effect of sildenafil citrate on endometrial development in women with history of recurrent implantation failure after IVF


Description:

sildenafil citrate may increase endometrial thickness in women with recurrent IVF failure attributed to poor endometrial development


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date August 10, 2017
Est. primary completion date August 1, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- (1) cases of infertility, older than 20 years of age and not older than 40 years.

- (2) Body mass index (BMI):20-29.

- (3) women have experienced two or more implantation failure attributed to inadequate endometrial development.

Exclusion Criteria:

- (1) Uterine abnormalities (e.g. septate, bicornuate and fibroid uterus, Asherman Syndrome).

- (2) Any contraindication to sildenafil citrate or any of the components of its formulation including:

- Concurrent use of organic nitrites and nitrates.

- Severe hepatic impairment.

- Severe renal impairment.

- Hypotension.

- Recent stroke or heart attack.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Sildenafil Citrate
25 mg orally, 4 times per day for 21 days
matching placebo
orally, 4 times per day for 21 days

Locations

Country Name City State
Egypt Ain shams university Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary endometrial thickness measures we will measure endometrial thickness by US in women with recurrent implantation failure 21 days